Skip to main content

Table 2 Antimicrobial susceptibility profile of K. pneumoniae isolates

From: Correlation between antimicrobial resistance and biofilm formation capability among Klebsiella pneumoniae strains isolated from hospitalized patients in Iran

Susceptibility profile SXT CTX FEP AN IPM MEM CRO GM CAZ CIP
MDR S 25 (37.3%) 26 (38.8%) 27 (40.3%) 55 (82.1%) 41 (61.2%) 38 (56.7%) 29 (43.3%) 48 (71.6%) 28 (41.7%) 19 (28.3%)
I 4 (5.9%) 8 (11.9%) 5 (7.5%) 5 (7.5%) 2 (2.9%) 1 (1.5%) 9 (13.4%) 2 (2.9%) 8 (11.9%) 4 (5.9%)
R 38 (56.7%) 33 (49.3%) 35 (52.2%) 7 (10.4%) 24 (35.8%) 28 (41.7%) 29 (43.3%) 17 (25.4%) 31 (46.3%) 44 (65.6%)
Non-MDR S 18 (54.5%) 22 (66.6%) 22 (66.6%) 31 (93.9%) 22 (66.6%) 23 (69.6%) 16 (48.5%) 25 (75.5%) 18 (54.5%) 19 (57.5%)
I 1 (3%) 4 (12.1%) 3 (9.1%) 2 (6.1%) 0 (0.0%) 1 (3%) 3 (9.1%) 0 (0.0%) 2 (6.1%) 5 (15.2%)
R 14 (42.4%) 18 (54.5%) 8 (24.2%) 0 (0.0%) 11 (33.3%) 9 (27.3%) 14 (42.4%) 8 (24.2%) 13 (39.4%) 9 (27.3%)
  1. MDR multidrug resistant, S susceptible, I intermediate resistant, R resistant, SXT Trimethoprim-sulfamethoxazole, CTX cefotaxime, FEP cefepime, AN amikacin, IPM imipenem, MEM meropenem, CRO ceftriaxone, GM gentamicin, CAZ ceftazidime, and CIP ciprofloxacin
\